Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mizagliflozin (KWA-0711) in Chronic Constipation
NCT02343978Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Dec 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of mizagliflozin in chronic constipation (2 arms), sponsored by Kissei Pharmaceutical Co., Ltd. Primary endpoint: Incidence of Adverse Events at 2 weeks. Started Dec 2014; status: completed.
02
Drugs
mizagliflozin
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT02343978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02343978.